TrialBMJ open2018

CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine.

Dan Siskind et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.